|[April 20, 2017]
Global $228.8 Billion Generic Drugs Market 2017-2022 - Key Players are Freseunis, Hospira, Mylan, Novartis, Sandoz & Teva Pharmaceuticals - Research and Markets
Research and Markets has announced the addition of the "Generic
Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2017-2022" report to their offering.
The global generic drugs market was valued at around US$ 228.8 Billion
in 2016, growing at a CAGR of around 9% during 2010-2016
The biggest catalyst for growth is an increasing global pharmaceutical
spending trend towards generics. Continuously increasing healthcare
expenditures have pushed governments and third-party payers to seek ways
to control their healthcare expenditures. This is catalyzing an
increasing demand for generics versus their branded counterparts.
Another major driver of this industry is the continued patent cliff that
is proiding growing pipelines opportunities for generic firms.
Similarly, a growth in the overall global population and aging
demographics is also proving to be beneficial for the overall healthcare
sector including generic drug manufacturers. Healthcare reforms in the
US and other developed markets coupled with strong growth in emerging
market are some other important drivers for the generic drugs market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
5 Global Generic Drug Industry
6 Performance of Key Regions
7 Competitive Landscape
8 Generic Drug Manufacturing Process
9 Project Details, Requirements and Costs Involved
10 Loans and Financial Assistance
11 Project Economics
Novartis - Sandoz
For more information about this report visit http://www.researchandmarkets.com/research/b6lxt6/generic_drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20170420006278/en/
[ Back To TMCnet.com's Homepage ]